Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Pfizer to form new business segments following Allergan deal
March 2016
EDIT CONNECT

SHARING OPTIONS:

NEW YORK—Pfizer Inc. has announced upcoming changes for the combined Pfizer and Allergan plc business in the wake of the Allergan transaction. The firms will operate as separate companies until the deal closes, which is expected in the second half of this year. After the close, Pfizer will manage the combined company’s commercial operations through two businesses: an Innovative Products business, which will consist of the Global Innovative Pharmaceutical and the Global Specialty and Consumer Brands segments, and an Established Products business, which will consist of the Global Established Pharmaceutical segment, including all legacy Hospira commercial operations. The new operating segment, Global Specialty and Consumer Brands, will include Pfizer’s Consumer Healthcare unit and Allergan’s ophthalmology and aesthetics businesses, as well as Botox Therapeutic and Cosmetic. Pfizer also noted that it plans to make a decision about a possible separation of the combined company’s established businesses no later than the end of 2018.
 
Code:

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.